GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » aap Implantate AG (HAM:AAQ1) » Definitions » Debt-to-EBITDA

aap Implantate AG (HAM:AAQ1) Debt-to-EBITDA : -1.25 (As of Jun. 2023)


View and export this data going back to 1999. Start your Free Trial

What is aap Implantate AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

aap Implantate AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €1.43 Mil. aap Implantate AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €1.14 Mil. aap Implantate AG's annualized EBITDA for the quarter that ended in Jun. 2023 was €-2.05 Mil. aap Implantate AG's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was -1.25.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for aap Implantate AG's Debt-to-EBITDA or its related term are showing as below:

HAM:AAQ1' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -11.42   Med: -0.6   Max: 0.46
Current: -1.81

During the past 13 years, the highest Debt-to-EBITDA Ratio of aap Implantate AG was 0.46. The lowest was -11.42. And the median was -0.60.

HAM:AAQ1's Debt-to-EBITDA is ranked worse than
100% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs HAM:AAQ1: -1.81

aap Implantate AG Debt-to-EBITDA Historical Data

The historical data trend for aap Implantate AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aap Implantate AG Debt-to-EBITDA Chart

aap Implantate AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -0.40 -0.81 -11.42 -2.09

aap Implantate AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.56 -4.85 -1.26 -4.22 -1.25

Competitive Comparison of aap Implantate AG's Debt-to-EBITDA

For the Medical Devices subindustry, aap Implantate AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aap Implantate AG's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's Debt-to-EBITDA falls into.



aap Implantate AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

aap Implantate AG's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.004 + 1.268) / -1.567
=-2.09

aap Implantate AG's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.425 + 1.137) / -2.054
=-1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2023) EBITDA data.


aap Implantate AG  (HAM:AAQ1) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


aap Implantate AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of aap Implantate AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


aap Implantate AG (HAM:AAQ1) Business Description

Traded in Other Exchanges
Address
Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.

aap Implantate AG (HAM:AAQ1) Headlines

No Headlines